Mason scientists develop COVID-19 antibody measurement technology to rapidly assess virus blocking efficacy Post author By Katie Maney Post date March 30, 2022 Yuntao Wu, Professor, Molecular & Microbiology, School of Systems Biology, George Mason University. Photo by Evan Cantwell/George Mason University ← The link between abortion and peer-to-peer lending → Risk of homelessness or incarceration among foster youth varies by type of disability
